252 related articles for article (PubMed ID: 34487155)
1. Patients Prioritize a Low-volume Bowel Preparation in Colitis-associated Colorectal Cancer Surveillance: A Discrete Choice Experiment.
Wijnands AM; Te Groen M; Peters Y; Kaptein AA; Oldenburg B; Hoentjen F; Lutgens MWMD
Inflamm Bowel Dis; 2022 Jul; 28(7):1053-1060. PubMed ID: 34487155
[TBL] [Abstract][Full Text] [Related]
2. Patients' perception of colonoscopy and acceptance of colonoscopy based IBD related colorectal cancer surveillance.
Braithwaite E; Carbonell J; Kane JS; Gracie D; Selinger CP
Expert Rev Gastroenterol Hepatol; 2021 Feb; 15(2):211-216. PubMed ID: 32981385
[TBL] [Abstract][Full Text] [Related]
3. Interval Colorectal Cancer in Inflammatory Bowel Disease: A Review.
Da Cunha T; Vaziri H
J Clin Gastroenterol; 2024 Jan; 58(1):1-11. PubMed ID: 37548445
[TBL] [Abstract][Full Text] [Related]
4. Estimating the preferences and willingness-to-pay for colorectal cancer screening: an opportunity to incorporate the perspective of population at risk into policy development in Thailand.
Phisalprapa P; Ngorsuraches S; Wanishayakorn T; Kositamongkol C; Supakankunti S; Chaiyakunapruk N
J Med Econ; 2021; 24(1):226-233. PubMed ID: 33467947
[TBL] [Abstract][Full Text] [Related]
5. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
6. Incidence of Interval Colorectal Cancer Among Inflammatory Bowel Disease Patients Undergoing Regular Colonoscopic Surveillance.
Mooiweer E; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; van Bodegraven AA; Jansen JM; Mahmmod N; Kremer W; Siersema PD; Oldenburg B;
Clin Gastroenterol Hepatol; 2015 Sep; 13(9):1656-61. PubMed ID: 25956835
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
Dyson JK; Rutter MD
World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
[TBL] [Abstract][Full Text] [Related]
8. Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey.
Baars JE; Kuipers EJ; van Haastert M; Nicolaï JJ; Poen AC; van der Woude CJ
J Gastroenterol; 2012 Dec; 47(12):1308-22. PubMed ID: 22627504
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous Preferences for Colorectal Cancer Screening in Germany: Results of a Discrete Choice Experiment.
Brinkmann M; Diedrich L; Hemmerling M; Krauth C; Robra BP; Stahmeyer JT; Dreier M
Value Health; 2023 Jan; 26(1):104-114. PubMed ID: 36031478
[TBL] [Abstract][Full Text] [Related]
10. Quality of Surveillance Impacts the Colitis-Associated Advanced Neoplasia Risk: A Multicenter Case-Control Study.
Te Groen M; Derks M; den Broeder N; Peters C; Dijkstra G; de Vries A; Romkens T; Horjus C; de Boer N; de Jong M; Nagtegaal I; Derikx L; Hoentjen F
Clin Gastroenterol Hepatol; 2024 Feb; 22(2):357-367.e5. PubMed ID: 36572110
[TBL] [Abstract][Full Text] [Related]
11. A rule for determining risk of colorectal cancer in patients with inflammatory bowel disease.
Lutgens M; Vermeire S; Van Oijen M; Vleggaar F; Siersema P; van Assche G; Rutgeerts P; Oldenburg B;
Clin Gastroenterol Hepatol; 2015 Jan; 13(1):148-54.e1. PubMed ID: 25041864
[TBL] [Abstract][Full Text] [Related]
12. Surveillance and management of colorectal dysplasia and cancer in inflammatory bowel disease: Current practice and future perspectives.
Wijnands AM; Mahmoud R; Lutgens MWMD; Oldenburg B
Eur J Intern Med; 2021 Nov; 93():35-41. PubMed ID: 34481721
[TBL] [Abstract][Full Text] [Related]
13. Colorectal Cancer Screening in Inflammatory Bowel Disease.
Sengupta N; Yee E; Feuerstein JD
Dig Dis Sci; 2016 Apr; 61(4):980-9. PubMed ID: 26646250
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer in inflammatory bowel disease: review of the evidence.
Keller DS; Windsor A; Cohen R; Chand M
Tech Coloproctol; 2019 Jan; 23(1):3-13. PubMed ID: 30701345
[TBL] [Abstract][Full Text] [Related]
15. High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance.
Singh K; Al Khoury A; Kurti Z; Gonczi L; Reinglas J; Verdon C; Kohen R; Bessissow T; Afif W; Wild G; Seidman E; Bitton A; Lakatos PL
J Crohns Colitis; 2019 Sep; 13(10):1343-1350. PubMed ID: 30918959
[TBL] [Abstract][Full Text] [Related]
16. Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease.
Shah SC; Glass J; Giustino G; Hove JRT; Castaneda D; Torres J; Kumar A; Elman J; Ullman TA; Itzkowitz SH
Gut Liver; 2019 Jan; 13(1):54-61. PubMed ID: 30400722
[TBL] [Abstract][Full Text] [Related]
17. Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease.
Eluri S; Parian AM; Limketkai BN; Ha CY; Brant SR; Dudley-Brown S; Efron JE; Fang SG; Gearhart SL; Marohn MR; Meltzer SJ; Bashar S; Truta B; Montgomery EA; Lazarev MG
Dig Dis Sci; 2017 Dec; 62(12):3586-3593. PubMed ID: 28631086
[TBL] [Abstract][Full Text] [Related]
18. Rate of early/missed colorectal cancers after colonoscopy in older patients with or without inflammatory bowel disease in the United States.
Wang YR; Cangemi JR; Loftus EV; Picco MF
Am J Gastroenterol; 2013 Mar; 108(3):444-9. PubMed ID: 23295277
[TBL] [Abstract][Full Text] [Related]
19. Root-cause analyses of missed opportunities for the diagnosis of colorectal cancer in patients with inflammatory bowel disease.
Gordon C; Chee D; Hamilton B; Heerasing NM; Hendy P; Chanchlani N; Lin S; Wesley E; Daniels IR; Silva N; Osborne M; Kennedy NA; Goodhand JR; Ahmad T
Aliment Pharmacol Ther; 2021 Jan; 53(2):291-301. PubMed ID: 33159472
[TBL] [Abstract][Full Text] [Related]
20. Adherence to endoscopic surveillance for advanced lesions and colorectal cancer in inflammatory bowel disease: an AEG and GETECCU collaborative cohort study.
Ballester MP; Mesonero F; Flórez-Diez P; Gómez C; Fuentes-Valenzuela E; Martín N; Senosiain C; Vela M; Fernández-Clotet A; Pérez P; Rubín de Célix C; Calviño-Suárez C; Hermida B; Muñoz R; González-Vivo M; Brunet E; Jiménez N; Botella B; Yebra J; Suárez-Ferrer C; Bouhmidi A; López-Serrano A; Ponferrada Á; Dueñas C; Mínguez M;
Aliment Pharmacol Ther; 2022 Jun; 55(11):1402-1413. PubMed ID: 35224758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
